MDM specializes in integrating finance, communication, marketing and securities law compliance to enable the most effective two-way communication between a company, its stakeholders and the financial community. We bring years of extensive experience, knowledge and expertise providing strategic counsel to dozens of small and mid-cap publicly traded companies, specifically as it relates to IPO’s, secondary offerings, PIPE’s, venture round and various M&A transactions.
We pride ourselves in our ability to assist our clients in navigating through fluctuating market cycles, various politically charged health care agendas and technology trends. MDM understands the many facets that impact the life sciences and technology sectors, and pays special attention to the factors that will influence our clients’ market perception and activity. MDM uses traditional stock intelligence, i.e. Security Position Reports, in conjunction with tracking and monitoring analytics to determine marketplace activity and will provide valuable feedback to our clients in real time. Based on this information, MDM is able to provide management with a detailed analysis of trading in their equity; therefore, affording the company an opportunity to determine how to properly address these items in the most effective manner.
An inherit risk of being a publicly traded company is the exposure to various events that can adversely impact value. Whether it’s a negative article, delayed or failed business program, or a management shakeup, crises are unexpected. They can do great harm, but, if appropriately addressed in a timely manner, companies can mitigate against some of the negative exposure that may ensue. While every crisis is unique, our approach, which is practical and at times unconventional, yields strong results for our clients.